A 58 year old patient with dementia, oral dyskinesia, and diabetes mellitus is described. He had an undetectable concentration of serum caeruloplasmin, as an autosomal recessive trait. Brain MRI disclosed a pronounced hypointensity in the bilateral putamina, caudate, and dentate nuclei on both Ti and T2 weighted images. Pathological findings were mainly in those regions of the brain and consisted of neuronal cell loss with gliosis, heavy iron deposition, and spheroids. 
Hereditary caeruloplasmin deficiency is a newly recognised disorder first described by Miyajima et serum concentrations of caeruloplasmin, which were consistent with heterozygotes of an autosomal recessive phenotype. The patient was found dead in his home and necropsy was performed 20 hours postmortem. Representative specimens from the brain and the visceral organs were processed for histopathological examination after fixing in 20% formaldehyde. Several specimens were examined histochemically with Perls' stain for iron and rhodanine and Shikata's stains for copper.
Necropsy results

NEUROPATHOLOGY
The brain weighted 1300 g and appeared normal externally. Macroscopic sections of the brain disclosed symmetric red-brown discoloration in the putamen, caudate nucleus, and cerebellar dentate nucleus (figure, B). Microscopic examination of those regions disclosed neuronal cell loss with reactive astrocytosis and deposition of many pigment granules (figure, C). Those granules yielded a strong reaction with Perls' stain, showing iron deposition in residual neurons, astrocytes, and neuropils around blood vessels (figure, D). Eosinophilic, round to oval non-nucleated structures consistent with spheroids were occasionally noted (figure, C). Astrocytosis in those lesions consisted mainly of hypertrophic astrocytes and many of them had iron pigments (figure, D which was first reported by Cox,"2 showed decreased serum caeruloplasmin concentrations in affected members of the family but the members were reported to have no medical problems.'2 13 It is uncertain whether they are heterozygotes for hereditary caeruloplasmin deficiency, because there are no chance matings of members with hypocaeruloplasminaemia from those families. '3 The common features of the patients are familial caeruloplasmin deficiency and iron deposition in the brain and liver. Caeruloplasmin's role in iron metabolism has been established in animal studies'4 and Miyajima et al' proposed a pathomechanism of tissue iron deposition caused by caeruloplasmin deficiency in humans. Caeruloplasmin is a copper containing protein with ferroxidase activity that oxidises ferrous iron (Fe (II)) to ferric iron (Fe (III)).'5 Because Fe III is the only iron form that can bind to apotransferrin and enter the bloodstream, caeruloplasmin deficiency would decrease recycling of iron from cell to plasma, resulting in cellular iron deposition.' Laboratory findings for the recorded patients and ours (table) show decreased iron but greatly increased ferritin concentrations in the serum that could be due to caeruloplasmin deficiency.
The present pathological findings correlate well with the clinical features of the other recorded patients and our patient (table). Iron deposition and neuronal cell loss in the putamen and caudate nucleus can explain subcortical dementia2 3 and involuntary movements such as blepharospasm.' Cerebellar Purkinje cell loss and the dentate nucleus lesion could result in cerebellar symptoms.3 Diabetes mellitus23 could be due to increased iron in the pancreas, resulting in impaired insulin secretion.'6 The brain MRI findings can be explained by massive iron deposition to the cerebral basal ganglia and cerebellar dentate nucleus. 17 The variation in clinical findings among the reported patients' 3 and the present one could be explained partly by the differences in the severity of iron deposition and subsequent tissue damage in affected organs of the body. Other factors such as differences in the mutations of the caeruloplasmin gene among the reported families4 5 9 could con-tribute to the variation of clinical presentations.
Striking features of the neuropathological changes in affected areas of our patient were neuronal cell loss, iron deposition, and spheroid formation, similar to those in Hallervorden-Spatz syndrome.10 1 1 The combination of iron deposition and spheroids in the same lesion had previously been considered unique to Hallervorden-Spatz syndrome." The distinction between our patient and patients with Hallervorden-Spatz syndrome is that our patient did not show severe pathological changes in the glubus pallidus and substantia nigra, and changes in those regions are the pathological hallmark of Hallervorden-Spatz syndrome.'0 1' It remains unexplained why similar histological changes occur in different areas of the brain in these different disorders. One hypothesis is that a metabolic block in recycling of cellular iron would produce similar pathological responses in the brain. In our patient, decreased ferroxidase activity due to caeruloplasmin deficiency could impair iron recycling in the brain and in HallervordenSpatz disease,'8 decreased cysteine dioxygenase activity has been proposed to cause iron accumulation in the globus pallidus. Variations among metabolic blocks in recycling of iron would determine selective vulnerability of brain regions and subsequent specific neurological abnormalities.
In conclusion, our patient and other patients reported'-3 constitute a clinicopathological disease entity of hereditary caeruloplasmin deficiency which shows clinical symptoms such as dementia, involuntary movements, and diabetes mellitus, and pathological iron deposition in the brain, liver, pancreas, and other organs. We propose the existence of a group of disorders caused by a metabolic defect in cellular recycling of iron in the brain. This includes hereditary caeruloplasmin deficiency and Hallervorden-Spatz syndrome, and these are different from diseases caused by iron overload, such as hereditary haemochromatosis.8
